Top of the morning to you. The middle of the week is upon us and, since you made it this far, why not forge ahead? After all, there is always light at the end of the proverbial tunnel. You never know what you may accomplish. So please join us as we celebrate this notion with a cup or three of delicious stimulation. Today, we are reaching for cinnamon hazelnut, a reliable and tasty choice. And as always, we have assembled a menu of tidbits to help you along. So please dig in. Have a smashing day, and please feel free to forward any secrets you come across. Our “in basket” is always open. …
Teva Pharmaceutical and Allergan, a unit of AbbVie, are willing to pay more than $5 billion combined to resolve more than 3,500 lawsuits filed against them over opioid painkillers, Bloomberg News reports. The drugmakers have been in mediation talks with plaintiffs for more than a year. While Teva and Allergan indicated a willingness to settle, no formal offer has been made or finalized, and talks are continuing. Details are unclear, since the companies are still arguing with each other over an indemnity agreement. In 2016, Teva paid more than $40 billion to buy Allergan’s line of generic opioid-based medicines, which Allergan claims shifted all its costs for generic opioids to Teva.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
